• Tues news: Prostate cancer trials to watch. Merck’s subcutaneous Keytruda. Apellis sees positive in Astellas CRL. Future of Medicare price negotiations. JNJ psoriasis results. See more on our front page

covid19

  1. Bioreference - something weird going on, anyone know what it is?

    Bioreference was kicking a** earlier this year: 3Q had 24% share of ACLA lab did 3.5mm PCR tests and routine testing down 9%. Averaged 39k/tests per day with capacity at 70k. then in October, testing went up 30%....and they dropped to 34k/day. Then they lost NBA contract and I heard trying to...
  2. SmileDirectClub posts wider loss in Q1

    SmileDirectClub, Inc. (SDC) reported a wider loss in the first quarter of 2020 due to higher costs and expenses. However, the top-line increased by 11% year-over-year driven by an increase in unique aligner shipments and higher average aligner gross sales price. Take a look at the visual...
  3. Regeneron advances in COVID-19 virus cure

    Regeneron Pharmaceuticals, Inc. (REGN) reported a 36% jump in earnings for the first quarter of 2020 helped by higher revenue. The results exceeded analysts’ expectations. The company is advancing REGN-COV2, a novel investigational antibody “cocktail” treatment designed to prevent and treat the...
  4. Covid-19 < MONEY!!

    Abbott Clonmel do not care about the Covid-19 pandemic. All they care about is their profits and bottom line. Social distancing is non existant on the production lines. It has been raised many times that we are not following the governments guidelines but nothing is being done about it. Targets...
  5. Need Info Roche SARS-CoV-2 Test for COVID-19.

    I'm doing some pro-bono research and consulting on the questions below regarding Roche SARS-CoV-2 Test for COVID-19. I AM NOT consulting or working for Roche! Has a cost or price been established for this test (lab &/or patient)? How many cobas® 6800 and cobas® 8800 Systems are installed in...
  6. Remember Patrick Vallance?

    He just fell in the same trap as when he was at GSK: trying to please his boss blurs his judgement. Number of victims will be higher this time.